Upstream Bio Statistics Share Statistics Upstream Bio has 53.79M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 53.79M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 84.39% Shares Floating n/a Failed to Deliver (FTD) Shares 13,475 FTD / Avg. Volume 3.05%
Short Selling Information The latest short interest is 3.78M, so 7.03% of the outstanding
shares have been sold short.
Short Interest 3.78M Short % of Shares Out 7.03% Short % of Float 12.72% Short Ratio (days to cover) 14.13
Valuation Ratios The PE ratio is -13.44 and the forward
PE ratio is -5.47.
Upstream Bio's PEG ratio is
-0.32.
PE Ratio -13.44 Forward PE -5.47 PS Ratio 356.14 Forward PS 587.9 PB Ratio 1.8 P/FCF Ratio -14.14 PEG Ratio -0.32
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Upstream Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 44.63,
with a Debt / Equity ratio of 0.
Current Ratio 44.63 Quick Ratio 44.63 Debt / Equity 0 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $45.58K Profits Per Employee $-1.21M Employee Count 52 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.64, so Upstream Bio's
price volatility has been higher than the market average.
Beta 1.64 52-Week Price Change n/a 50-Day Moving Average 11.98 200-Day Moving Average 13.07 Relative Strength Index (RSI) 71.09 Average Volume (20 Days) 441,670
Income Statement In the last 12 months, Upstream Bio had revenue of 2.37M
and earned -62.81M
in profits. Earnings per share was -1.49.
Revenue 2.37M Gross Profit 2.37M Operating Income -77.76M Net Income -62.81M EBITDA -77.67M EBIT -77.76M Earnings Per Share (EPS) -1.49
Full Income Statement Balance Sheet The company has 325.89M in cash and 1.83M in
debt, giving a net cash position of 324.06M.
Cash & Cash Equivalents 325.89M Total Debt 1.83M Net Cash 324.06M Retained Earnings -190.78M Total Assets 456.17M Working Capital 444.22M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -59.17M
and capital expenditures -511K, giving a free cash flow of -59.68M.
Operating Cash Flow -59.17M Capital Expenditures -511K Free Cash Flow -59.68M FCF Per Share -1.16
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -3281.18% and -2650.04%.
Gross Margin 100% Operating Margin -3281.18% Pretax Margin -2650.04% Profit Margin -2650.04% EBITDA Margin -3277.43% EBIT Margin -3281.18% FCF Margin -2518.27%
